Lipella Pharmaceuticals earnings were -$5.0M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest LIPO earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$1.4M, down 0.2% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, LIPO reported annual earnings of -$5.0M, with 8.6% growth.
Lipella Pharmaceuticals Earnings Reports & History FAQ
What were Lipella Pharmaceuticals's earnings last quarter?
Lipella Pharmaceuticals (NASDAQ: LIPO) reported Q4 2024 earnings per share (EPS) of -$1.19, up 72.46% year over year. Total LIPO earnings for the quarter were -$1.44 million. In the same quarter last year, Lipella Pharmaceuticals's earnings per share (EPS) was -$0.69.
Is Lipella Pharmaceuticals profitable or losing money?
As of the last Lipella Pharmaceuticals earnings report, Lipella Pharmaceuticals is currently losing money. Lipella Pharmaceuticals's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$5.02 million, a 8.6% increase year over year.
What was LIPO's earnings growth in the past year?
As of Lipella Pharmaceuticals's earnings date in Q2 2025, Lipella Pharmaceuticals's earnings has grown year over year. LIPO earnings in the past year totalled -$5.02 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.